Prevalence of co-infection of human immunodeficiency virus in diagnosed tuberculosis cases: Meta-analysis

Authors

  • Naif H Alanazi College of Health Science, Saudi Electronic University, Riyadh, Saudi Arabia
  • Asif Hanif a:1:{s:5:"en_US";s:63:"University Institute of Public health, The university of Lahore";}

Keywords:

Co-infection, HIV, Meta-analysis, Pooled prevalence, Systematic review, Tuberculosis

Abstract

Objective: The objective of the study was to find pooled prevalence and risk factors of co-infection of human immunodeficiency virus (HIV) in diagnosed tuberculosis (TB) cases.
Methods: Search engines including PubMed and Google Scholar were used to find literature using search terms such as “co-infection,” “HIV,” “Acquired Immunodeficiency Syndrome,” TB and “Prevalence” among others. All original studies
conducted on the prevalence of HIV co-infection among diagnosed TB patients that were freely available in full length had a clear methodology and relevant results were included in the study.
Results: From 1021 initial studies, a total of 18 studies were selected for analysis. A total of 18 studies were included with a total sample size of 44943. The minimum prevalence of HIV-TB was reported in a study from Pakistan as 0.29% and the
maximum prevalence of HIV-TB was found in Nigeria, that is, 44.20%. The pooled prevalence of HIV/TB co-infection was 16.291% (95%; 9.57–24.38) using the random effect method. As per Begg’s test, there was no publication bias. As I2 is 99.74% so, there is high heterogeneity among studies; hence, random effect model is preferred.
Conclusion: The study concludes that the pooled prevalence of HIV/TB co-infection was found to be 16.291% (95%; 9.57–24.38). The risk of mortality will be substantially raised by the co-existence of HIV-TB co-infection, so early screening and emphasizing the urgent need for integrated health-care interventions can cope with the situation.

Downloads

Published

2024-03-01

How to Cite

Alanazi, N. H., & Hanif, A. (2024). Prevalence of co-infection of human immunodeficiency virus in diagnosed tuberculosis cases: Meta-analysis. International Journal of Health Sciences, 18(2), 56–61. Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/8471

Issue

Vol. 18 No. 2 (2024): Mar-Apr

Section

Reviews

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.


Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).